Download Now: Exclusive Guide About India's Potentially Decade-Long $10 Trillion Bull Run...
Here is the latest financial fact sheet of WELCURE DRUG. For more details, see the WELCURE DRUG quarterly results and WELCURE DRUG share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.0 |
No. of shares | m | 13.51 |
1 Week | % | 10.2 |
1 Month | % | 25.2 |
1 Year | % | 20.2 |
52 week H/L | Rs | 5.5/3.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
WELCURE DRUG EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1 | 1 | 2 | 12 | 12 | |
Low | Rs | 1 | NA | NA | 2 | 4 | |
Sales per share (Unadj.) | Rs | 0.1 | 0.1 | 0.1 | 0.1 | 0 | |
Earnings per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0.1 | |
Diluted earnings per share | Rs | 0.0 | -0.0 | 0.0 | 0.0 | 0.1 | |
Cash flow per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 0 | 0 | 0.1 | 0.1 | 1.1 | |
Adj. book value per share | Rs | 0.0 | 0.0 | 0.1 | 0.1 | 1.1 | |
Shares outstanding (eoy) | m | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | |
Price / Sales ratio | x | 16.1 | 8.1 | 13.5 | 89.8 | 0 | |
Avg P/E ratio | x | 320.9 | -70.4 | 32.5 | 401.1 | 100.7 | |
P/CF ratio (eoy) | x | 320.9 | -70.4 | 32.5 | 401.1 | 97.5 | |
Price / Book Value ratio | x | 54.1 | 46.9 | 25.9 | 101.3 | 6.8 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 13 | 7 | 18 | 94 | 102 | |
Total wages/salary | Rs m | 0 | 0 | 0 | 0 | 0 |
WELCURE DRUG INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1 | 1 | 1 | 1 | 0 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 2 | |
Total revenues | Rs m | 1 | 1 | 1 | 1 | 2 | |
Gross profit | Rs m | 0 | 0 | 1 | 0 | -1 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | 0 | 0 | 1 | 0 | 1 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | 0 | 0 | 1 | 0 | 1 | |
Gross profit margin | % | 2.9 | -11.6 | 41.4 | 22.5 | 0 | |
Effective tax rate | % | 0 | 0 | 0 | 0 | 0 | |
Net profit margin | % | 4.9 | -11.3 | 41.5 | 22.5 | 0 |
WELCURE DRUG BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 0 | 0 | 1 | 1 | 0 | |
Current liabilities | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net working cap to sales | % | 29.6 | 17.2 | 52.2 | 59.2 | 0 | |
Current ratio | x | 5.0 | 2.5 | 18.3 | 16.5 | 0.4 | |
Inventory Days | Days | 0 | 0 | 0 | 107 | 0 | |
Debtors Days | Days | 0 | 0 | 0 | 0 | 0 | |
Net fixed assets | Rs m | 0 | 0 | 0 | 0 | 15 | |
Share capital | Rs m | 121 | 121 | 121 | 121 | 134 | |
"Free" reserves | Rs m | -121 | -121 | -120 | -120 | -119 | |
Net worth | Rs m | 0 | 0 | 1 | 1 | 15 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 0 | 0 | 1 | 1 | 15 | |
Interest coverage | x | 0 | 0 | 0 | 0 | 0 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 2.7 | 3.3 | 1.8 | 1.1 | 0 | |
Return on assets | % | 13.2 | -37.2 | 75.7 | 24.4 | 6.7 | |
Return on equity | % | 16.2 | -67.1 | 79.9 | 25.4 | 6.7 | |
Return on capital | % | 16.5 | -66.4 | 80.1 | 25.4 | 6.7 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
WELCURE DRUG CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 0 | -0 | 0 | 0 | 1 | |
From Investments | Rs m | 0 | 0 | 0 | 0 | 13 | |
From Financial Activity | Rs m | 0 | 0 | 0 | 0 | -15 | |
Net Cashflow | Rs m | 0 | -0 | 0 | 0 | -1 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Altaf Hussain Shah | COMP SEC: Manowar Ali | YEAR OF INC: 1996 | BSE CODE: 524661 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare WELCURE DRUG With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian shares rose cautiously on Friday as markets sobered up to the idea that U.S. rate cuts were most likely some time away.